Medicare Fraud EXPOSED: Seniors Over-Medicated for Profit

(DailyChive.com) – Government-designed Medicare payment incentives are systematically rewarding healthcare providers for over-medicating seniors and inflating diagnoses, turning what should be patient care into a profit-driven scheme that endangers our most vulnerable citizens.

Story Snapshot

Medicare Advantage plans profit from upcoding diagnoses and prescribing excessive medications to seniors
Justice Department launched probe into UnitedHealth Group following 2025 Wall Street Journal exposé
Polypharmacy affecting 50+ percent of Medicare beneficiaries costs taxpayers $2 billion annually
Government incentives reward documenting more illnesses while offering no compensation for reducing medications

Medicare’s Perverse Payment Structure Fuels Medical Excess

The Centers for Medicare and Medicaid Services has created a system where insurance companies receive higher payments for patients with more documented diagnoses. This risk-adjustment formula encourages Medicare Advantage plans to maximize the number of conditions recorded for each beneficiary, regardless of medical necessity. The Cato Institute analysis reveals that over 50 percent of seniors now enrolled in these plans face systematic upcoding practices that inflate their apparent health complexity for financial gain.

Wall Street Journal Exposes Industry-Wide Fraud Schemes

January 2025 brought shocking revelations when the Wall Street Journal documented how major insurers, including UnitedHealth Group, deploy nurses to seniors’ homes specifically to identify “missed” diagnoses that can boost reimbursement rates. These visits prioritize revenue generation over patient welfare, with healthcare workers trained to find billable conditions rather than improve health outcomes. The Justice Department’s February 2025 probe into UnitedHealth signals federal recognition of this systematic abuse of Medicare dollars.

Polypharmacy Crisis Endangers Senior Health and Drains Taxpayers

Seniors taking eleven or more medications face nearly double the risk of medication-related problems compared to those on fewer drugs. Research shows each additional prescription increases adverse effects by ten percent, leading to preventable hospitalizations, falls, and dangerous drug interactions. Yet physicians receive no reimbursement for the time-intensive process of deprescribing unnecessary medications, while adding new prescriptions requires minimal effort and generates neutral financial outcomes for providers.

Government Incentives Override Medical Judgment

The current payment structure creates moral hazard where medical decisions serve financial rather than clinical purposes. Physicians face time pressures that make prescribing easier than deprescribing, while Medicare Advantage plans profit from maintaining complex medication regimens that justify higher risk scores. This government-designed system contradicts decades of clinical guidelines, including the Beers Criteria established in 1991, which specifically warns against inappropriate medication use in elderly patients.

The Cato Institute’s analysis demonstrates how federal payment policies transform healthcare from a healing profession into a revenue optimization exercise. When government bureaucrats design incentive structures that reward excess over outcomes, patients suffer while taxpayers fund a system that prioritizes profit over the constitutional principle of limited, effective government. Real reform requires dismantling these perverse incentives, not adding more regulations to a fundamentally flawed framework.